Concentric Capital Strategies’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-128,900
Closed -$29.1M 256
2024
Q4
$29.1M Buy
+128,900
New +$28.8M 1.34% 10

Other funds holding MSGS

Concentric Capital Strategies's MSGS Position: Q2 2026 in Review

Concentric Capital Strategies reduced its Madison Square Garden (MSGS) stake by 37% in Q2 2026, selling an estimated $6.46M and leaving 31,238 shares worth $12.6M. The position accounts for 0.7% of the portfolio, ranked #13.

Concentric Capital Strategies first reported a position in MSGS in Q3 2022 and has held it in 16 quarters since. The position peaked at $31.1M in Q4 2025. 469 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

  • Concentric Capital Strategies held 31,238 shares of Madison Square Garden worth $12.6M as of Q2 2026.
  • Concentric Capital Strategies sold 18,229 Madison Square Garden shares in Q2 2026, an estimated $6.46M.
  • Madison Square Garden made up 0.7% of Concentric Capital Strategies's portfolio in Q2 2026, its #13 holding.
  • Concentric Capital Strategies first reported a position in Madison Square Garden in Q3 2022 and has held it in 16 quarters since.
  • Concentric Capital Strategies's Madison Square Garden position peaked at $31.1M in Q4 2025.
  • 469 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on Concentric Capital Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.